Wall Street Journal : Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion

 

#Business #WallStreet

The deal is the latest example of a big pharma company turning to the deal table to bolster its pipeline of autoimmune drugs.

Read More  

WSJ.com: US Business  

PAID 

This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.

Leave a Reply

Generated by Feedzy